Proteon logo     Print Page | Close Window

SEC Filings

8-A12B
PROTEON THERAPEUTICS INC filed this Form 8-A12B on 10/16/2014
Entire Document
 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-A

 

FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES

PURSUANT TO SECTION 12(b) OR (g) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Proteon Therapeutics, Inc.

 (Exact name of registrant as specified in its charter)

 

Delaware

 

20-4580525

(State of incorporation or organization)

 

(I.R.S. Employer Identification No.)

 

200 West Street

Waltham, MA 02451

(781) 890-0102

(Address of principal executive offices and zip code)

 

Securities to be registered pursuant to Section 12(b) of the Act:

 

Title of each class

to be so registered

 

Name of each exchange on which

each class is to be registered

 

 

 

Common Stock, $0.001 par value per share

 

The NASDAQ Stock Market LLC

 

If this form relates to the registration of a class of securities pursuant to Section 12(b) of the Exchange Act and is effective pursuant to General Instruction A.(c), please check the following box. x

 

If this form relates to the registration of a class of securities pursuant to Section 12(g) of the Exchange Act and is effective pursuant to a General Instruction A.(d), please check the following box. o

 

Securities Act registration statement file number to which this form relates (if applicable): 333-198777

 

Securities to be registered pursuant to Section 12(g) of the Act: None.